Aphria is engaged in the production, supply and sale of medical cannabis in Canada. Co.'s medical cannabis is 100% greenhouse grown and comes in a range of products such as capsules, oral solutions, syringes and vaporizers. Co.'s cannabis capsules contain a precise dose of active cannabinoids in the form of purified cannabis oil. Co.'s oral solution contains purified cannabis oil in a liquid form. Co.'s syringe products are versatile and can be consumed in various forms, including orally or heated at a high temperature. Co.'s single-unit vaporizer cartridges are pre-filled with purified cannabis oil made from cannabis plant extract and natural terpenes. The APHA average annual return since 2017 is shown above.
The Average Annual Return on the APHA average annual return since 2017 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether APHA average annual return since 2017 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the APHA average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|